Brought to you by 
Daktari Diagnostics brings in $10mm
03 Mar 2015
Executive Summary
In what appears to be its third financing, Daktari Diagnostics Inc. (developed a CD4 cell counting system) raised $10mm in a round of equity and debt from lead investor Merck Global Health Innovation Fund and returning shareholders Norwich Ventures and Partners Innovation Fund. According to the Form D filing, a total of 41 investors participated. The money will be used to finish developing and launch its initial products for HIV monitoring.
Deal Industry
- In Vitro Diagnostics
-
Medical Devices
- Diagnostic Imaging Equipment & Supplies
-
In Vitro Diagnostics
- Chemistry, Immunoassay
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Daktari Diagnostics brings in $10mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice